The vaccine from Pfizer / BioNTech has in an experiment with children aged 12-15 years shown an effect of 100 percent in relation to protection against coronavirus.
This is stated by Pfizer in a statement.
The companies will use the results to apply to be allowed to give the vaccine to children up to 12 years of age.
Today, the vaccine is approved for everyone over the age of 16. Pfizer / BioNTech plans to apply to expand the age group with children aged 12-15 years.
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), respectively, will assess whether to extend the use of the vaccine. Applications will be sent ‘as soon as possible’.
The National Board of Health must give the green light
Although Pfizer / BioNTech should be given the green light to give the vaccine to children up to the age of 12, it is not certain that the vaccine will also end up being offered to children.
In Denmark, it will be up to the National Board of Health to assess whether the vaccine will be offered to children.
In the trial with the vaccine in question, 2260 children aged 12 to 15 years participated, where about half have received the vaccine and half have received placebo.
In the placebo group, there were 18 cases where children became ill with coronavirus, while no one in the group received the vaccine.